Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
Status:
Completed
Trial end date:
2016-09-06
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of the administration of aflibercept by intravitreal
injection in comparison to sham to control intraocular pressure in patients with neovascular
glaucoma.